Cipher Pharmaceuticals (CPH) News Today C$15.64 +0.34 (+2.22%) As of 08/28/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock CPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period TSE:CPH FY2025 EPS Forecast Cut by Leede FinancialAugust 15, 2025 | marketbeat.comCipher Pharmaceuticals’ Record Earnings Driven by NatrobaAugust 13, 2025 | msn.comCipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record RevenueAugust 8, 2025 | theglobeandmail.comCipher Pharmaceuticals (TSE:CPH) Stock Price Passes Below 50-Day Moving Average - Here's WhyJuly 26, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average - Should You Sell?July 17, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Price Crosses Below 50-Day Moving Average - Here's What HappenedJune 27, 2025 | marketbeat.comCPH - Cipher Pharmaceuticals Inc Key Metrics - MorningstarJune 24, 2025 | morningstar.comMCipher Pharmaceuticals (TSE:CPH) Stock Price Passes Above 50-Day Moving Average - Here's WhyJune 3, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Shares Pass Above Fifty Day Moving Average - Here's What HappenedMay 18, 2025 | marketbeat.comEarnings call transcript: Cipher Pharmaceuticals misses Q1 2025 EPS expectationsMay 11, 2025 | uk.investing.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Below 50 Day Moving Average - Should You Sell?April 26, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Passes Below 50-Day Moving Average - What's Next?April 17, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Given a C$12.50 Price Target by Canaccord Genuity Group AnalystsApril 9, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average - What's Next?April 4, 2025 | marketbeat.comWhat is Stifel Canada's Forecast for TSE:CPH Q1 Earnings?March 27, 2025 | marketbeat.comHarold Morton Wolkin Sells 3,500 Shares of Cipher Pharmaceuticals Inc. (TSE:CPH) StockMarch 25, 2025 | marketbeat.comCipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in StockMarch 25, 2025 | insidertrades.comLeede Financial Estimates TSE:CPH FY2027 EarningsMarch 24, 2025 | marketbeat.comTSE:CPH FY2025 EPS Estimate Lowered by Leede FinancialMarch 22, 2025 | marketbeat.comEarnings call transcript: Cipher Pharmaceuticals Q4 2024 sees stock surgeMarch 21, 2025 | uk.investing.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 ResultsMarch 19, 2025 | theglobeandmail.comCipher Pharmaceuticals Inc.'s (TSE:CPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?March 17, 2025 | uk.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average - Here's WhyMarch 11, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Crosses Below 50 Day Moving Average - Should You Sell?February 22, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Below Fifty Day Moving Average - Here's What HappenedFebruary 5, 2025 | marketbeat.comCipher Pharmaceuticals Inc. (TSE:CPH) most popular amongst individual investors who own 57%, insiders hold 42%February 4, 2025 | finance.yahoo.comThis Healthcare Stock Could Be the Best Investment of the DecadeJanuary 31, 2025 | msn.com1 Canadian Stock Ready to Start 2025 With a BangJanuary 30, 2025 | fool.ca5 Best-performing Canadian Pharma Stocks (Updated January 2025)January 11, 2025 | msn.comCipher Pharmaceuticals (TSE:CPH) Stock Price Crosses Above 50 Day Moving Average - Here's What HappenedJanuary 10, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average - Time to Sell?January 10, 2025 | marketbeat.comThose who invested in Cipher Pharmaceuticals (TSE:CPH) five years ago are up 883%December 25, 2024 | finance.yahoo.comStifel Canada Has Positive View of TSE:CPH FY2025 EarningsDecember 6, 2024 | marketbeat.comLeede Financial Analysts Cut Earnings Estimates for TSE:CPHNovember 11, 2024 | marketbeat.comCipher Pharmaceuticals Third Quarter 2024 Earnings: EPS Misses ExpectationsNovember 10, 2024 | uk.finance.yahoo.comCipher Pharmaceuticals Reports Third Quarter 2024 ResultsNovember 8, 2024 | theglobeandmail.comCipher Pharmaceuticals’ Revenue Soars After Natroba AcquisitionNovember 7, 2024 | markets.businessinsider.comWhat To Expect From Cipher Pharmaceuticals Inc (TSX:CPH) Q3 2024 EarningsNovember 7, 2024 | finance.yahoo.comEarnings To Watch: Cipher Pharmaceuticals Inc (TSX:CPH) Reports Q3 2024 ResultNovember 6, 2024 | finance.yahoo.comCipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference CallNovember 4, 2024 | finance.yahoo.comStifel Canada Issues Negative Estimate for TSE:CPH EarningsOctober 25, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) PT Raised to C$19.00 at Stifel NicolausOctober 24, 2024 | marketbeat.comEquities Analysts Offer Predictions for TSE:CPH Q4 EarningsOctober 24, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Crosses Above 50 Day Moving Average - Here's WhyOctober 4, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Below Fifty Day Moving Average of $14.21September 25, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Rating Lowered by Leede FinancialSeptember 17, 2024 | marketbeat.comCanadian Investment Regulatory Organization Trading Halt - CPHSeptember 14, 2024 | ca.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Shares Down 18.3% September 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $19.69August 29, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $16.60August 22, 2024 | marketbeat.com Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPH Media Mentions By Week CPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPH News Sentiment▼0.001.03▲Average Medical News Sentiment CPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPH Articles This Week▼01▲CPH Articles Average Week Get the Latest News and Ratings for CPH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cipher Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TLRY News CRON News GUD News ACB News WEED News OGI News CRDL News RX News HLS News SUGR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CPH) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cipher Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access